annual accounts payable:
$11.39M-$24.48M(-68.25%)Summary
- As of today (June 22, 2025), ARWR annual accounts payable is $11.39 million, with the most recent change of -$24.48 million (-68.25%) on September 30, 2024.
- During the last 3 years, ARWR annual accounts payable has risen by +$1.93 million (+20.42%).
- ARWR annual accounts payable is now -68.25% below its all-time high of $35.87 million, reached on September 30, 2023.
Performance
ARWR Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$9.98M-$4.48M(-30.97%)Summary
- As of today (June 22, 2025), ARWR quarterly accounts payable is $9.98 million, with the most recent change of -$4.48 million (-30.97%) on March 31, 2025.
- Over the past year, ARWR quarterly accounts payable has increased by +$1.46 million (+17.12%).
- ARWR quarterly accounts payable is now -72.17% below its all-time high of $35.87 million, reached on September 30, 2023.
Performance
ARWR quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ARWR Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.3% | +17.1% |
| 3 y3 years | +20.4% | -5.9% |
| 5 y5 years | +48.9% | -25.6% |
ARWR Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.3% | +297.1% | -72.2% | +1153.8% |
| 5 y | 5-year | -68.3% | +297.1% | -72.2% | +1153.8% |
| alltime | all time | -68.3% | >+9999.0% | -72.2% | >+9999.0% |
ARWR Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $9.98M(-31.0%) |
| Dec 2024 | - | $14.46M(+26.9%) |
| Sep 2024 | $11.39M(-68.2%) | $11.39M(-57.1%) |
| Jun 2024 | - | $26.55M(+211.6%) |
| Mar 2024 | - | $8.52M(+91.1%) |
| Dec 2023 | - | $4.46M(-87.6%) |
| Sep 2023 | $35.87M(+1150.6%) | $35.87M(+355.5%) |
| Jun 2023 | - | $7.87M(-17.6%) |
| Mar 2023 | - | $9.56M(+1100.5%) |
| Dec 2022 | - | $796.00K(-72.2%) |
| Sep 2022 | $2.87M(-69.7%) | $2.87M(-51.3%) |
| Jun 2022 | - | $5.89M(-44.4%) |
| Mar 2022 | - | $10.60M(+160.6%) |
| Dec 2021 | - | $4.07M(-57.0%) |
| Sep 2021 | $9.46M(+38.5%) | $9.46M(-5.8%) |
| Jun 2021 | - | $10.04M(+89.4%) |
| Mar 2021 | - | $5.30M(+9.8%) |
| Dec 2020 | - | $4.83M(-29.3%) |
| Sep 2020 | $6.83M(-10.7%) | $6.83M(+67.6%) |
| Jun 2020 | - | $4.07M(-69.6%) |
| Mar 2020 | - | $13.42M(+10.0%) |
| Dec 2019 | - | $12.20M(+59.5%) |
| Sep 2019 | $7.65M(+172.6%) | $7.65M(+65.2%) |
| Jun 2019 | - | $4.63M(+14.0%) |
| Mar 2019 | - | $4.06M(+3.2%) |
| Dec 2018 | - | $3.94M(+40.3%) |
| Sep 2018 | $2.81M(-31.2%) | $2.81M(+29.6%) |
| Jun 2018 | - | $2.17M(+19.6%) |
| Mar 2018 | - | $1.81M(-68.3%) |
| Dec 2017 | - | $5.71M(+40.0%) |
| Sep 2017 | $4.08M(-66.7%) | $4.08M(+26.1%) |
| Jun 2017 | - | $3.23M(+24.5%) |
| Mar 2017 | - | $2.60M(-29.8%) |
| Dec 2016 | - | $3.70M(-69.8%) |
| Sep 2016 | $12.23M(+143.1%) | $12.23M(+105.8%) |
| Jun 2016 | - | $5.95M(-21.2%) |
| Mar 2016 | - | $7.54M(+42.6%) |
| Dec 2015 | - | $5.29M(+5.1%) |
| Sep 2015 | $5.03M(+95.1%) | $5.03M(+3.5%) |
| Jun 2015 | - | $4.86M(-1.5%) |
| Mar 2015 | - | $4.94M(-17.7%) |
| Dec 2014 | - | $6.00M(+132.4%) |
| Sep 2014 | $2.58M(+115.0%) | $2.58M(+19.5%) |
| Jun 2014 | - | $2.16M(-14.1%) |
| Mar 2014 | - | $2.51M(+326.2%) |
| Dec 2013 | - | $589.30K(-50.9%) |
| Sep 2013 | $1.20M(+36.6%) | $1.20M(+13.0%) |
| Jun 2013 | - | $1.06M(+21.8%) |
| Mar 2013 | - | $871.70K(+7.7%) |
| Dec 2012 | - | $809.50K(-7.8%) |
| Sep 2012 | $878.00K | $878.00K(-11.7%) |
| Jun 2012 | - | $994.40K(+24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $801.10K(+12.2%) |
| Dec 2011 | - | $714.10K(+23.8%) |
| Sep 2011 | $576.80K(-15.4%) | $576.80K(+15.1%) |
| Jun 2011 | - | $501.30K(+112.5%) |
| Mar 2011 | - | $235.90K(-90.3%) |
| Dec 2010 | - | $2.42M(+255.6%) |
| Sep 2010 | $681.60K(-32.7%) | $681.60K(-34.0%) |
| Jun 2010 | - | $1.03M(+16.8%) |
| Mar 2010 | - | $884.00K(-0.9%) |
| Dec 2009 | - | $891.70K(-12.0%) |
| Sep 2009 | $1.01M(-24.5%) | $1.01M(-27.6%) |
| Jun 2009 | - | $1.40M(-30.1%) |
| Mar 2009 | - | $2.00M(+4.7%) |
| Dec 2008 | - | $1.91M(+42.4%) |
| Sep 2008 | $1.34M(-0.5%) | $1.34M(+23.8%) |
| Jun 2008 | - | $1.08M(-6.6%) |
| Mar 2008 | - | $1.16M(+31.7%) |
| Dec 2007 | - | $880.90K(-34.7%) |
| Sep 2007 | $1.35M(+59.4%) | $1.35M(-7.2%) |
| Jun 2007 | - | $1.45M(+196.7%) |
| Mar 2007 | - | $490.00K(+25.1%) |
| Dec 2006 | - | $391.60K(-53.7%) |
| Sep 2006 | $846.60K(+79.4%) | $846.60K(+304.5%) |
| Jun 2006 | - | $209.30K(-87.8%) |
| Mar 2006 | - | $1.71M(+249.3%) |
| Dec 2005 | - | $490.90K(+4.0%) |
| Sep 2005 | $471.90K(-12.7%) | $471.90K(+37.8%) |
| Jun 2005 | - | $342.50K(-22.9%) |
| Mar 2005 | - | $444.50K(+56.5%) |
| Dec 2004 | - | $284.10K(-47.5%) |
| Sep 2004 | $540.70K(+483.3%) | $540.70K(+82.2%) |
| Jun 2004 | - | $296.80K(+839.2%) |
| Mar 2004 | - | $31.60K(+112.1%) |
| Dec 2003 | - | $14.90K(-83.9%) |
| Sep 2003 | $92.70K(-64.1%) | $92.70K(-70.8%) |
| Jun 2003 | - | $317.40K(+6.2%) |
| Mar 2003 | - | $298.90K(+9.4%) |
| Dec 2002 | - | $273.30K(+5.7%) |
| Sep 2002 | $258.50K(+43.6%) | $258.50K(+4.7%) |
| Jun 2002 | - | $246.90K(+1.5%) |
| Mar 2002 | - | $243.20K(+16.7%) |
| Dec 2001 | - | $208.40K(+15.8%) |
| Sep 2001 | $180.00K(+12.0%) | $180.00K(+7.6%) |
| Jun 2001 | - | $167.30K(-0.7%) |
| Mar 2001 | - | $168.50K(+8.4%) |
| Dec 2000 | - | $155.50K(-3.2%) |
| Sep 2000 | $160.70K(-5.0%) | $160.70K(-29.7%) |
| Jun 2000 | - | $228.70K(+9.6%) |
| Mar 2000 | - | $208.70K(+11.9%) |
| Dec 1999 | - | $186.50K |
| Sep 1999 | $169.10K(-88.0%) | - |
| Sep 1998 | $1.41M(-0.7%) | - |
| Sep 1997 | $1.42M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual accounts payable year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly accounts payable year-on-year change?
What is Arrowhead Pharmaceuticals annual accounts payable?
The current annual accounts payable of ARWR is $11.39M
What is the all time high annual accounts payable for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual accounts payable is $35.87M
What is Arrowhead Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ARWR annual accounts payable has changed by -$24.48M (-68.25%)
What is Arrowhead Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ARWR is $9.98M
What is the all time high quarterly accounts payable for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly accounts payable is $35.87M
What is Arrowhead Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ARWR quarterly accounts payable has changed by +$1.46M (+17.12%)